Literature DB >> 20104200

Microbiologic and clinical features of Salmonella species isolated from bacteremic children in eastern Democratic Republic of Congo.

Olivier Vandenberg1, Deo Z Nyarukweba, Prudence M Ndeba, Rene S Hendriksen, Ezra J Barzilay, Carole Schirvel, Balaluka B Bisimwa, Jean-Marc Collard, Awa Aidara Kane, Frank M Aarestrup.   

Abstract

BACKGROUND: The morbidity of Salmonella bloodstream infections is unacceptably high in Africa. In 2000, the WHO Global Salmonella-Surveillance (GSS) program was founded to reduce the health burden of foodborne diseases. The incorporation, in 2002, of the Democratic Republic of Congo (DRC) in this program allowed the improvement of laboratory capacities. In this retrospective study, we describe the first signs of impact the GSS program has had in DRC in the management of bacteremia.
METHODS: Between 2002 and 2006, we evaluated, in one pediatric hospital, the microbiologic and clinical features of Salmonella isolated from children suspected of having bacteremia. A random selection of isolates was typed by pulsed field gel electrophoresis (PFGE).
RESULTS: Among the 1528 children included in the study, 26.8% were bacteremic. Salmonella accounted for 59% of all bloodstream infections. Salmonella typhimurium (60.5%) and Salmonella enteritidis (22.3%) were the most common Salmonella serotypes. In total, 92.4% were resistant to at least 3 antimicrobials with the following proportion of strains resistant to: ampicillin (86%), chloramphenicol (92%), trimethoprim/sulfamethoxazole (95%), and tetracycline (34%). In 2002, 32.1% of children received an appropriate empiric antimicrobial treatment. In 2006, with the restoration of the confidence in the results provided by the laboratory, we observed an increase of the proportion of patients appropriately (82.9%) treated with antimicrobials (P < 0.01) without any decrease in the overall mortality rates associated with salmonellae bacteremia.
CONCLUSIONS: Our findings indicate the benefit to strengthen laboratory capacities in Africa, allowing the development of management guidelines of bloodstream infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20104200     DOI: 10.1097/INF.0b013e3181cd615a

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  19 in total

1.  Factors associated with occurrence of salmonellosis among children living in Mukuru slum, an urban informal settlement in Kenya.

Authors:  Cecilia Mbae; Moses Mwangi; Naomi Gitau; Tabitha Irungu; Fidelis Muendo; Zilla Wakio; Ruth Wambui; Susan Kavai; Robert Onsare; Celestine Wairimu; Ronald Ngetich; Frida Njeru; Sandra Van Puyvelde; John Clemens; Gordon Dougan; Samuel Kariuki
Journal:  BMC Infect Dis       Date:  2020-06-17       Impact factor: 3.090

2.  Extremely drug-resistant Salmonella enterica serovar Senftenberg infections in patients in Zambia.

Authors:  Rene S Hendriksen; Katrine Grimstrup Joensen; Chileshe Lukwesa-Musyani; Annie Kalondaa; Pimlapas Leekitcharoenphon; Ruth Nakazwe; Frank M Aarestrup; Henrik Hasman; James C L Mwansa
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

Review 3.  Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now?

Authors:  Samuel Kariuki; Kelvin Kering; Celestine Wairimu; Robert Onsare; Cecilia Mbae
Journal:  Infect Drug Resist       Date:  2022-07-07       Impact factor: 4.177

Review 4.  Antibacterial resistance in sub-Saharan Africa: an underestimated emergency.

Authors:  Samuel Kariuki; Gordon Dougan
Journal:  Ann N Y Acad Sci       Date:  2014-03-14       Impact factor: 5.691

5.  The consequences of a sudden demographic change on the seroprevalence pattern, virulence genes, identification and characterisation of integron-mediated antibiotic resistance in the Salmonella enterica isolated from clinically diarrhoeic humans in Egypt.

Authors:  K M Osman; W M M Hassan; R A H Mohamed
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-18       Impact factor: 3.267

6.  Epidemic increase in Salmonella bloodstream infection in children, Bwamanda, the Democratic Republic of Congo.

Authors:  M-F Phoba; H De Boeck; B B Ifeka; J Dawili; O Lunguya; R Vanhoof; J-J Muyembe; C Van Geet; S Bertrand; J Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-24       Impact factor: 3.267

7.  Salmonella typhi in the democratic republic of the congo: fluoroquinolone decreased susceptibility on the rise.

Authors:  Octavie Lunguya; Veerle Lejon; Marie-France Phoba; Sophie Bertrand; Raymond Vanhoof; Jan Verhaegen; Anthony Marius Smith; Karen Helena Keddy; Jean-Jacques Muyembe-Tamfum; Jan Jacobs
Journal:  PLoS Negl Trop Dis       Date:  2012-11-15

8.  Cost-effectiveness analysis of diagnostic options for pneumocystis pneumonia (PCP).

Authors:  Julie R Harris; Barbara J Marston; Nalinee Sangrujee; Desiree DuPlessis; Benjamin Park
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

9.  Are Salmonella-Induced Gastroenteritis Neglected in Developing Countries? Feedback from Microbiological Investigations in N'Djamena Hospitals, Chad.

Authors:  Djim-Adjim Tabo; Sophie A Granier; Colette D Diguimbaye; Muriel Marault; Anne Brisabois; Baïzina Mama; Yves Millemann
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

10.  Antimicrobial resistance in invasive non-typhoid Salmonella from the Democratic Republic of the Congo: emergence of decreased fluoroquinolone susceptibility and extended-spectrum beta lactamases.

Authors:  Octavie Lunguya; Veerle Lejon; Marie-France Phoba; Sophie Bertrand; Raymond Vanhoof; Youri Glupczynski; Jan Verhaegen; Jean-Jacques Muyembe-Tamfum; Jan Jacobs
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.